CATX Perspective Therapeutics, Inc.
2.460USD+4.24%Mkt Cap: 280.81M $P/E: —1d ago
Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. It discovers and develops its initial …
Industry Peers
Medical Devices$171.97BUSDP/E 31.8
$109.38BUSDP/E 21.0
$105.64BUSDP/E 28.5
$60.26BUSDP/E 16.8
$49.39BUSDP/E 51.1
$46.91BUSDP/E 19.6
$31.81BUSDP/E 33.5
$29.42BUSDP/E 14.9
$23.55BUSDP/E 18.0
$22.87BUSDP/E 18.7
$20.44BUSDP/E 25.6
$17.11BUSDP/E 28.0
$16.88BUSDP/E 21.5
$12.46BUSDP/E 77.7
$11.25BUSDP/E 18.3
$10.16BUSD
$9.87BUSDP/E 28.0
$9.92BUSD
$9.90BUSDP/E 18.9
$9.85BUSDP/E 46.6
Key Statistics
Company
Market Cap280.81M USD
Enterprise Value36.48M USD
Revenue (TTM)409.00K USD
Gross Profit-95.77M USD
Net Income (TTM)-103.12M USD
Revenue/Share0.0040 USD
Last Price2.460 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees163
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.30
PEG—
EV/EBITDA-0.30
EV/Revenue89.21
P/S658.67
P/B0.83
EPS (TTM)-1.33
EPS (Forward)-1.02
52W Range
1.96012% of range6.160
52W High6.160 USD
52W Low1.960 USD
Profitability
Gross Margin0.00%
Oper. Margin-36120.99%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-49.81%
ROA-38.63%
Growth
Revenue Growth-72.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-82.48M USD
CapEx (TTM)12.75M USD
FCF Margin-16974.48%
FCF Yield-24.72%
Net Debt-232.91M USD
Net Debt/EBITDA1.92
Balance Sheet
Debt/Equity0.02
Current Ratio6.61
Quick Ratio6.49
Book Value/Sh2.84 USD
Cash/Share2.08 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJun 17, 2024
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)12.29 USD
Upside (mean)+399.4%
Target Range5.000 USD – 18.00 USD
5.000+399.4% to mean18.00
# Analysts14
Ownership
Shares Out.114.15M
Float70.82M
Insiders8.23%
Institutions86.01%
Short Interest
Short Ratio19.6d
Short % Float23.86%
Short % Out.19.98%
Shares Short22.81M
Short (prev mo.)23.04M
Technical
SMA 502.967 (-17.1%)
SMA 2003.608 (-31.8%)
Beta1.85
S&P 52W Chg16.45%
Avg Vol (30d)1.68M
Avg Vol (10d)2.42M
Technical Indicators
RSI (14)38.7
MACD-0.1473
MACD Signal-0.1216
MACD Hist.-0.0257
BB Upper3.289 USD
BB Middle2.773 USD
BB Lower2.257 USD
BB Width37.21%
ATR (14)0.2059 USD
Vol Ratio (20d)0.66x